Volume 26, Issue 5 pp. 329-331
Short Report

Pseudolymphoma Syndrome due to Carbamazepine

Hidehisa Saeki

Corresponding Author

Hidehisa Saeki

Division of Dermatology, Tokyo Teishin Hospital, Tokyo, Japan

Reprint requests to: Hidehisa Saeki, M.D., Division of Dermatology, Tokyo Teishin Hospital, Fujimi 2-14-23, Chiyoda-ku, Tokyo 102-0071, Japan.Search for more papers by this author
Takafumi Etoh

Takafumi Etoh

Division of Dermatology, Tokyo Teishin Hospital, Tokyo, Japan

Search for more papers by this author
Kiyoshi Toda

Kiyoshi Toda

Division of Dermatology, Tokyo Teishin Hospital, Tokyo, Japan

Search for more papers by this author
Martin C. Mihm Jr

Martin C. Mihm Jr

Division of Dermatology, Tokyo Teishin Hospital, Tokyo, Japan

Division of Dermatopathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, U.S.A.

Search for more papers by this author
First published: 09 April 2015
Citations: 11

Abstract

We described a 29-year-old Japanese woman with a pseudolymphoma syndrome due to carbamazepine. Physical examination revealed a diffuse erythematous papular eruption over almost all of her body with generalized lymphadenopathy. Histopathologic examination disclosed histology compatible with the nodular pattern of pseudo-T-cell lymphoma. The Southern blot analysis did not disclose the monoclonality of the gamma T cell recepter gene. We consider that it is very important to recognize this pseudolymphoma syndrome due to carbamazepine to avoid possibly subjecting the patient to unnecessary chemotherapy.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.